Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PhaseBio Pharmaceuticals, Inc. PHAS

Set alert

Price alert · PHAS

All alert types
0.07 0.00 0.00%

At close · Nov 2

0.0665 Day range 0.092

52-week range unavailable

Open
0.0807
Prev close
0.0701
Mkt cap
0
Vol
8.60M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0665
High
0.092
Forward P/E
0.00
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2022
50-d avg
0.00
200-d avg
0.00
1y target
1.00

3M chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The three-month price history for PHAS has not been loaded yet. Try again in a moment.

Valuation

P/E -580×
FY 2016: -6.8×FY 2017: -5.5×FY 2018: -0.7×FY 2019: -4.3×FY 2020: -1.0×FY 2021: -580×
FY 2016 5y median -4.3× FY 2021
P/S 7084×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 24.5×FY 2019: 71.2×FY 2020: 305×FY 2021: 7084×
FY 2016 5y median 71.2× FY 2021
P/B -0.8×
FY 2016: -0.7×FY 2017: -0.6×FY 2018: 0.3×FY 2019: 2.8×FY 2020: -3.9×FY 2021: -0.8×
FY 2016 5y median -0.6× FY 2021
P/FCF -1.5×
FY 2016: -6.3×FY 2017: -6.6×FY 2018: -1.0×FY 2019: -4.1×FY 2020: -1.6×FY 2021: -1.5×
FY 2016 5y median -1.6× FY 2021
EV/EBITDA 25.7×
FY 2016: -6.4×FY 2017: -7.9×FY 2018: 1.9×FY 2019: -2.9×FY 2020: -0.8×FY 2021: 25.7×
FY 2016 5y median -0.8× FY 2021
EV/Sales 3949×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -55.6×FY 2019: 46.0×FY 2020: 255×FY 2021: 3949×
FY 2016 5y median 46.0× FY 2021
FCF Yield -65.3%
FY 2016: -15.8%FY 2017: -15.1%FY 2018: -104.8%FY 2019: -24.1%FY 2020: -62.9%FY 2021: -65.3%
FY 2016 5y median -62.9% FY 2021

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 0.1%FY 2021: 100.0%
FY 2016 5y median 100.0% FY 2021
Operating Margin -1204.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -2940.7%FY 2019: -1683.0%FY 2020: -26517.5%FY 2021: -1204.1%
FY 2016 5y median -1683.0% FY 2021
Net Margin -1210.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -3569.8%FY 2019: -1662.3%FY 2020: -30801.6%FY 2021: -1210.1%
FY 2016 5y median -1662.3% FY 2021
ROE 0.1%
FY 2016: 10.6%FY 2017: 10.5%FY 2018: -46.8%FY 2019: -65.4%FY 2020: 391.1%FY 2021: 0.1%
FY 2016 5y median 0.1% FY 2021
ROIC -0.3%
FY 2016: -290.3%FY 2017: 244.2%FY 2018: -33.6%FY 2019: -52.0%FY 2020: -208.2%FY 2021: -0.3%
FY 2016 5y median -33.6% FY 2021
ROA -0.2%
FY 2016: -223.9%FY 2017: -72.7%FY 2018: -37.8%FY 2019: -47.6%FY 2020: -195.7%FY 2021: -0.2%
FY 2016 5y median -47.6% FY 2021

Growth (YoY)

Revenue -96.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 253.4%FY 2020: -86.4%FY 2021: -96.6%
FY 2016 FY 2021
Operating Income 99.8%
FY 2016: 0.0%FY 2017: 10.1%FY 2018: -130.1%FY 2019: -102.3%FY 2020: -113.5%FY 2021: 99.8%
FY 2016 FY 2021
EPS (diluted) 99.9%
FY 2016: 0.0%FY 2017: -23.0%FY 2018: -393.4%FY 2019: 68.2%FY 2020: -137.1%FY 2021: 99.9%
FY 2016 FY 2021
Free Cash Flow 18.4%
FY 2016: 0.0%FY 2017: 13.4%FY 2018: -102.6%FY 2019: -136.2%FY 2020: -51.3%FY 2021: 18.4%
FY 2016 FY 2021

Financial Health

Current Ratio 1.7×
FY 2016: 4.6×FY 2017: 0.8×FY 2018: 13.7×FY 2019: 9.3×FY 2020: 2.7×FY 2021: 1.7×
FY 2016 5y median 2.7× FY 2021
Quick Ratio 1.7×
FY 2016: 4.6×FY 2017: 0.8×FY 2018: 13.7×FY 2019: 9.3×FY 2020: 2.7×FY 2021: 1.7×
FY 2016 5y median 2.7× FY 2021
Debt / Equity -0.1×
FY 2016: 0.0×FY 2017: -0.2×FY 2018: 0.1×FY 2019: 0.2×FY 2020: -0.5×FY 2021: -0.1×
FY 2016 5y median -0.1× FY 2021
Net Debt / EBITDA -20.4×
FY 2016: 0.4×FY 2017: -0.3×FY 2018: 2.7×FY 2019: 1.6×FY 2020: 0.2×FY 2021: -20.4×
FY 2016 5y median 0.2× FY 2021
Interest Coverage 138×
FY 2016: 0.0×FY 2017: -3.1×FY 2018: -5.0×FY 2019: -36.9×FY 2020: -58.7×FY 2021: 138×
FY 2016 5y median -5.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31